These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 7963811

  • 61. Monitoring local disposition kinetics of carboplatin in vivo after subcutaneous injection in rats by means of 195Pt NMR.
    Becker M, Port RE, Zabel HJ, Zeller WJ, Bachert P.
    J Magn Reson; 1998 Jul; 133(1):115-22. PubMed ID: 9654475
    [Abstract] [Full Text] [Related]

  • 62. [The pharmacokinetics of intraperitoneal (IP) carboplatin (CBDCA) and dose-up study of intravenous (IV) cyclophosphamide (CPM) in combination with IP CBCDA for advanced ovarian cancer patients].
    Fujiwara K, Yamauchi H, Sawada S, Koike H, Mohri H, Ohishi Y, Kohno I.
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2373-9. PubMed ID: 1463344
    [Abstract] [Full Text] [Related]

  • 63. Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agent.
    Kim DK, Kim HT, Cho YB, Tai JH, Ahn JS, Kim TS, Kim KH, Hong WS.
    Cancer Chemother Pharmacol; 1995 Dec; 35(5):441-5. PubMed ID: 7850928
    [Abstract] [Full Text] [Related]

  • 64. Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat.
    Vadiei K, Siddik ZH, Khokhar AR, al-Baker S, Sampedro F, Perez-Soler R.
    Cancer Chemother Pharmacol; 1992 Dec; 30(5):365-9. PubMed ID: 1505075
    [Abstract] [Full Text] [Related]

  • 65. Nonuniform alteration of cis-diamminedichloroplatinum(II) tissue distribution in dogs with whole body hyperthermia.
    Riviere JE, Page RL, Rogers RA, Chang SK, Dewhirst MW, Thrall DE.
    Cancer Res; 1990 Apr 01; 50(7):2075-80. PubMed ID: 2317796
    [Abstract] [Full Text] [Related]

  • 66. Comparison of intestinal toxic effects of platinum complexes: cisplatin (CDDP), carboplatin (CBDCA), and iproplatin (CHIP).
    Kralovánszky J, Prajda N, Kerpel-Fronius S, Gál F, Kiss F.
    Cancer Chemother Pharmacol; 1988 Apr 01; 21(1):40-4. PubMed ID: 3277733
    [Abstract] [Full Text] [Related]

  • 67. Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer.
    Morgan RJ, Synold TW, Gandara D, Muggia F, Scudder S, Reed E, Margolin K, Raschko J, Leong L, Shibata S, Tetef M, Vasilev S, McGonigle K, Longmate J, Yen Y, Chow W, Somlo G, Carroll M, Doroshow JH.
    Cancer Chemother Pharmacol; 2004 Oct 01; 54(4):283-9. PubMed ID: 15184995
    [Abstract] [Full Text] [Related]

  • 68. Tissue platinum after clinical treatment with cisplatin or carboplatin in tumor-bearing patients.
    Minami T, Tohno Y, Tohno S, Utsumi M, Yamada M, Hashii K, Tateyama I, Kadota E, Okazaki Y.
    Biol Trace Elem Res; 1997 Oct 01; 58(1-2):77-83. PubMed ID: 9363322
    [Abstract] [Full Text] [Related]

  • 69. [Isolation of cisplatin-resistant subline from human ovarian cancer cell line and analysis of its cell-biological characteristics].
    Yoshiya N, Adachi S, Misawa Y, Yuzawa H, Honda T, Kanazawa K, Takeuchi S Tanaka K, Tanaka K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan 01; 41(1):7-14. PubMed ID: 2647872
    [Abstract] [Full Text] [Related]

  • 70. Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits.
    Najjar TA, Saad SY.
    Chemotherapy; 2001 Jan 01; 47(2):128-35. PubMed ID: 11173815
    [Abstract] [Full Text] [Related]

  • 71. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
    Akamatsu K, Saito H, Tsunenari T, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1993 Jan 01; 13(6A):2261-5. PubMed ID: 8297143
    [Abstract] [Full Text] [Related]

  • 72. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck.
    Jeremic B, Milicic B, Dagovic A, Vaskovic Z, Tadic L.
    J Clin Oncol; 2004 Sep 01; 22(17):3540-8. PubMed ID: 15337803
    [Abstract] [Full Text] [Related]

  • 73. Similar effects of cis-diamminedichloroplatinum(II) and cis-diammine-1,1-cyclobutanedicarboxylatoplatinum(II) on sodium-coupled glucose uptake in renal brush-border membrane vesicles.
    Potdevin S, Courjault-Gautier F, Ripoche P, Toutain HJ.
    Arch Toxicol; 1998 Oct 01; 72(10):663-70. PubMed ID: 9851683
    [Abstract] [Full Text] [Related]

  • 74. [Studies on pharmacokinetics of platinum after internal iliac artery infusion of cisplatin in rabbits].
    Kanamori Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Jan 01; 45(1):31-7. PubMed ID: 8436840
    [Abstract] [Full Text] [Related]

  • 75. Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells.
    Misawa T, Kikkawa F, Maeda O, Obata NH, Higashide K, Suganuma N, Tomoda Y.
    Jpn J Cancer Res; 1995 Jan 01; 86(1):88-94. PubMed ID: 7737915
    [Abstract] [Full Text] [Related]

  • 76. Interaction of platinum complexes of thiazin and xanthene dyes with hyperthermia.
    Herman TS, Teicher BA, Pfeffer MR, Khandekar VS, Alvarez Sotomayor E.
    Cancer Chemother Pharmacol; 1990 Jan 01; 26(2):127-34. PubMed ID: 2347038
    [Abstract] [Full Text] [Related]

  • 77. [Cytokinetic effects of carboplatin and cisplatin on a human ovarian cancer cell line].
    Yoshizumi N, Fujiwara J, Yoshizaki A, Sato M, Sakai R, Nishiya I.
    Hum Cell; 1988 Sep 01; 1(3):301-7. PubMed ID: 2979207
    [Abstract] [Full Text] [Related]

  • 78. Carboplatin pharmacokinetics following a single-dose infusion in sulphur-crested cockatoos (Cacatua galerita).
    Filippich LJ, Charles BG, Sutton RH, Bucher AM.
    Aust Vet J; 2004 Jun 01; 82(6):366-9. PubMed ID: 15267096
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.